PBE vs. IDNA ETF Comparison

Comparison of PowerShares Dynamic Biotech & Genome (PBE) to iShares Genomics Immunology and Healthcare ETF (IDNA)
PBE

PowerShares Dynamic Biotech & Genome

PBE Description

The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$75.24

Average Daily Volume

8,521

Number of Holdings *

30

* may have additional holdings in another (foreign) market
IDNA

iShares Genomics Immunology and Healthcare ETF

IDNA Description The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Grade (RS Rating)

Last Trade

$46.01

Average Daily Volume

94,208

Number of Holdings *

45

* may have additional holdings in another (foreign) market
Performance
PBE IDNA
30 Days -0.89% -4.05%
60 Days -8.26% -13.22%
90 Days -1.18% -10.35%
12 Months 44.39% 48.31%
6 Overlapping Holdings
Grade Symbol Weight in PBE Weight in IDNA Overlap
D BPMC 2.71% 3.67% 2.71%
F FGEN 1.05% 1.22% 1.05%
B FPRX 4.55% 1.34% 1.34%
C NTLA 3.52% 2.76% 2.76%
F SGEN 4.89% 3.22% 3.22%
F SGMO 2.79% 1.02% 1.02%
PBE Overweight 24 Positions Relative to IDNA
Grade Symbol Weight
A TECH 5.64%
B AMGN 5.51%
B QGEN 5.19%
A ALXN 5.11%
C CTLT 4.86%
F BMRN 4.86%
D ILMN 4.6%
B VCEL 3.48%
A UTHR 3.29%
C IRWD 3.17%
D PACB 2.98%
C ALKS 2.71%
F OPK 2.68%
D MYGN 2.61%
B DRNA 2.59%
D CDNA 2.55%
D VCYT 2.52%
C HALO 2.47%
D XNCR 2.47%
D PGEN 2.36%
D FLGT 2.3%
F EBS 2.24%
D ARWR 2.15%
D MNKD 2.13%
PBE Underweight 39 Positions Relative to IDNA
Grade Symbol Weight
D BGNE -5.6%
D FATE -5.02%
C EXEL -4.92%
C GILD -4.27%
A BNTX -4.11%
C REGN -3.89%
C MRNA -3.73%
F TAK -3.69%
D TWST -3.48%
F CRSP -3.17%
F NVTA -3.02%
C NSTG -2.43%
F EDIT -1.92%
D LGND -1.87%
D SWTX -1.85%
F SRPT -1.8%
F ALLO -1.76%
D VIR -1.61%
F BLUE -1.47%
C BCRX -1.41%
B MGNX -1.35%
F INO -1.14%
F CNST -0.66%
F ARCT -0.55%
F ADAP -0.54%
D ZIOP -0.53%
F VXRT -0.48%
D IBRX -0.47%
F PSNL -0.43%
D TCRR -0.42%
D ISEE -0.36%
F AGEN -0.35%
F ALGS -0.33%
F ALT -0.32%
F DTIL -0.3%
D CTMX -0.27%
D RAPT -0.26%
F MTEM -0.24%
F SYRS -0.21%
Compare ETFs